Anti-CD3/Anti-BCMA Bispecific Antibody TQB2934

**Semantic type:** Amino Acid, Peptide, or Protein|Immunologic Factor|Pharmacologic Substance

**Definition:** A T-cell engaging, human, bispecific, immunoglobulin G1 (IgG1) monoclonal antibody directed against the tumor-associated antigen (TAA) human B-cell maturation antigen (BCMA; tumor necrosis factor receptor superfamily member 17; TNFRSF17) and CD3 antigen found on T-lymphocytes, with potential immunostimulating and antineoplastic activities. Upon administration, anti-CD3/anti-BCMA bispecific antibody TQB2934 binds to both CD3 on cytotoxic T-lymphocytes (CTLs) and BCMA found on BCMA-expressing tumor cells. This activates and redirects CTLs to BCMA-expressing tumor cells, which results in the CTL-mediated cell death of BCMA-expressing tumor cells. BCMA, a member of the tumor necrosis factor receptor superfamily that is specifically overexpressed on malignant plasma cells, plays a key role in promoting plasma cell survival.

**Synonyms:** - Anti-BCMA/Anti-CD3 Bispecific Antibody TQB2934 - Anti-CD3 x BCMA Double-specific Antibody TQB2934 - Anti-CD3/Anti-BCMA T-cell Engaging Bispecific Antibody TQB2934 - Anti-CD3/BCMA Bispecific Antibody TQB2934 - Bispecific Antibody TQB2934 - TQB 2934 - TQB-2934 - TQB2934